Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (4): 710-715. doi: 10.19723/j.issn.1671-167X.2021.04.015
Previous Articles Next Articles
PANG Yong,ZHANG Sha,YANG Hua,ZHOU Rou-li()
CLC Number:
[1] |
Shao GZ, Zhou RL, Zhang QY, et al. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma [J]. Oncogene, 2003, 22(32):5060-5069.
doi: 10.1038/sj.onc.1206832 |
[2] |
Yang H, Xiong FX, Lin M, et al. LAPTM4B-35 is a novel diagnostic marker and a prognostic factor of hepatocellular carcinoma [J]. J Surgical Oncology, 2010, 101(5):363-369.
doi: 10.1002/jso.v101:5 |
[3] |
Yang H, Xiong FX, Lin M, et al. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma [J]. J Cancer Res Clin Oncol, 2010, 136(2):275-281.
doi: 10.1007/s00432-009-0659-4 pmid: 19690886 |
[4] | 何静, 邵根泽, 周柔丽, 等. 肝癌中高表达的新基因LAPTM4B对细胞增殖及成瘤性的影响 [J]. 北京大学学报(医学版), 2003, 35(4):348-352. |
[5] |
Li L, Shan Y, Yang H, et al. Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line [J]. Anat Rec (Hoboken), 2011, 294(7):1135-1142.
doi: 10.1002/ar.v294.7 |
[6] |
Liu XR, Xiong FX, Wei XH, et al. LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of HCC cells [J]. Cancer Sci, 2009, 100(12):2335-2340.
doi: 10.1111/cas.2009.100.issue-12 |
[7] |
Li L, Wei XH, Pan YP, et al. LAPTM4B: A novel cancer-asso-ciated gene motivates multi-drug resistance through efflux and activating PI3K/Akt signaling [J]. Oncogene, 2010, 29(43):5785-5795.
doi: 10.1038/onc.2010.303 pmid: 20711237 |
[8] |
Yang H, Xiong FX, Wei XH, et al. LAPTM4B-35 promotes growth and metastasis of hepatocelluar carcinoma [J]. Cancer Lett, 2010, 264(2):209-217.
doi: 10.1016/j.canlet.2008.01.025 |
[9] | 刘歆荣, 周柔丽, 张青云, 等. 人肝癌相关新基因编码产物LAPTM4B的鉴定及其生物学特性 [J]. 北京大学学报(医学版), 2003, 35(4):340-347. |
[10] |
Keller S, Sanderson MP, Stoeck A, et al. Exosomes: from biogenesis and secretion to biological function [J]. Immunol Lett, 2006, 107(2):102-108.
doi: 10.1016/j.imlet.2006.09.005 |
[11] |
Simons M, Raposo G. Exosomes: vesicular carriers for intercellular communication [J]. Curr Opin Cell Biol, 2009, 21(4):575-581.
doi: 10.1016/j.ceb.2009.03.007 |
[12] |
Simpson RJ. Exosomes: proteomic insights and diagnostic potential [J]. Expert Rev Proteomics, 2009, 6(3):267-283.
doi: 10.1586/epr.09.17 |
[13] |
Mitchell PJ, Welton J, Staffurth J. Can urinary exosomes act as treatment response markers in prostate cancer? [J]. J Transl Med, 2009, 7:4.
doi: 10.1186/1479-5876-7-4 pmid: 19138409 |
[14] |
Nilsson J, Skog J, Nordstrand A, et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer [J]. Br J Cancer, 2009, 100(10):1603-1607.
doi: 10.1038/sj.bjc.6605058 |
[15] | Théry C, Amigorena S, Raposo G, et al. Isolation and characte-rization of exosomes from cell culture supernatants and biological fluids [J]. Curr Protoc Cell Biol, 2006, Chapter 3: Unit 3.22. |
[16] |
Navabi H, Croston D, Hobot J, et al. Preperation of human ova-rian cancer ascites-derived exosomes for a clinical trial [J]. Blood Cells Mol Dis, 2005, 35(2):149-152.
doi: 10.1016/j.bcmd.2005.06.008 |
[17] |
Houali K, Wang X, Shimizu Y, et al. A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1, oncoproteins in the serum and saliva of patients with nasopharyn-geal carcinoma [J]. Clin Cancer Res, 2007, 13(17):4993-5000.
pmid: 17785549 |
[18] |
Viaud S, Théry C, Ploix S, et al. Dendritic cell-derived exosomes for cancer immunotherapy: what’s next? [J]. Cancer Res, 2010, 70(4):1281-1285.
doi: 10.1158/0008-5472.CAN-09-3276 |
[19] | Koga K, Matsumoto K, Akiyoshi T, et al. Purification, characte-rization and biological significance of tumor-derived exosomes [J]. Anticancer Res, 2005, 25(6A):3703-3707. |
[20] | Zhou RL. LAPTM4B: a novel diagnostic biomarker and therapeutic target for hepatocellular carcinoma [M]// Wan-Yee Lau. Hepatocellular carcinoma: Basic research. Philippines: InTech Press, 2012: 1-34. |
[21] |
Yang Z, Senninger N, Flammang I, et al. Clinical impact of circulating LAPTM4B-35 in pancreatic ductal adenocarcinoma [J]. J Cancer Res Clin Oncol, 2019, 145(5):1165-1178.
doi: 10.1007/s00432-019-02863-w |
[1] | Ting-ting DING,Chu-xiong ZENG,Li-na HU,Ming-hua YU. Establishment of a prediction model for colorectal cancer immune cell infiltration based on the cancer genome atlas (TCGA) database [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 203-208. |
[2] | Shu-lei WANG,Yang-xu GAO,Hong-wu ZHANG,Hai-bo YANG,Hui LI,Yu LI,Li-xue SHEN,Hong-xin YAO. Clinical analysis of 30 cases of basal ganglia germinoma in children [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 222-226. |
[3] | Guo-zhong LIN,Chang-cheng MA,Chao WU,Yu SI. Microscopic resection of lumbar intraspinal tumor through keyhole approach: A clinical study of 54 cases [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 315-319. |
[4] | Bing-yu LI,Zu-nan TANG,Lei-hao HU,Wen-bo ZHANG,Yao YU,Guang-yan YU,Xin PENG. Clinicopathologic analysis of micro and mini parotid gland tumors [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 335-339. |
[5] | LI Jun,LIU Xu-hong,WANG Gong,CHENG Cheng,ZHUANG Hong-qing,YANG Rui-jie. Dosimetric effect of patient arm position on Cyberknife radiosurgery for spinal tumors [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 182-186. |
[6] | Duo YANG,Xin-na ZHOU,Shuo WANG,Xiao-li WANG,Yan-hua YUAN,Hua-bin YANG,Hui-zhen GENG,Bing PENG,Zi-bo LI,Bin LI,Jun REN. Assessment of lymphocytic function in vitro stimulated by specific tumor polypeptide combined with dendritic cells [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1094-1098. |
[7] | Xue LOU,Li LIAO,Xing-jun LI,Nan WANG,Shuang LIU,Ruo-mei CUI,Jian XU. Methylation status and expression of TWEAK gene promoter region in peripheral blood of patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1020-1025. |
[8] | Yu TIAN,Xiao-yue CHENG,Hui-ying HE,Guo-liang WANG,Lu-lin MA. Clinical and pathological features of renal cell carcinoma with urinary tract tumor thrombus: 6 cases report and literature review [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 928-932. |
[9] | ZHAO Xun,YAN Ye,HUANG Xiao-juan,DONG Jing-han,LIU Zhuo,ZHANG Hong-xian,LIU Cheng,MA Lu-lin. Influence of deep invasive tumor thrombus on the surgical treatment and prognosis of patients with non-metastatic renal cell carcinoma complicated with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 665-670. |
[10] | YANG Rong,LI Qing-xiang,WANG Yi-fei,ZHOU Wen,WANG Wen,GUO Chuan-bin,LIU Hao,GUO Yu-xing. Application of iodine staining technique for tumor identification in Micro-CT of mouse model with skull base-infratemporal fossa tumor [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 598-601. |
[11] | ZHOU Chuan, MA Xue, XING Yun-kun, LI Lu-di, CHEN Jie, YAO Bi-yun, FU Juan-ling, ZHAO Peng. Exploratory screening of potential pan-cancer biomarkers based on The Cancer Genome Atlas database [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 602-607. |
[12] | CHEN Huai-an,LIU Shuo,LI Xiu-jun,WANG Zhe,ZHANG Chao,LI Feng-qi,MIAO Wen-long. Clinical value of inflammatory biomarkers in predicting prognosis of patients with ureteral urothelial carcinoma [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 302-307. |
[13] | YANG Yang,XIAO Feng,WANG Jin,SONG Bo,LI Xi-hui,ZHANG Shi-jie,HE Zhi-song,ZHANG Huan,YIN Ling. One-stage surgery in patients with both cardiac and non-cardiac diseases [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 327-331. |
[14] | Qi KANG,Ji-xin ZHANG,Ying GAO,Jun-qing ZHANG,Xiao-hui GUO. Analysis of diagnosis and treatment of 100 patients with Hürthle cell adenoma [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1098-1101. |
[15] | Zu-nan TANG,Yuh SOH Hui,Lei-hao HU,Yao YU,Wen-bo ZHANG,Xin PENG. Application of mixed reality technique for the surgery of oral and maxillofacial tumors [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1124-1129. |
|